Catalysis of drug oxidation during embryogenesis in human hepatic tissues using imipramine as a model substrate

Drug Metabolism and Disposition

Volumn 27, Issue 11, 1999, Pages 1306-1308

  Chen, Hao ^a   Brzezinski, Monica R ^a   Fantel, Alan G ^a   Juchau, Mont R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA NAPHTHOFLAVONE; COMPLEMENTARY DNA; CYTOCHROME P450; DESIPRAMINE; DIETHYLDITHIOCARBAMIC ACID; FURAFYLLINE; IMIPRAMINE; TROLEANDOMYCIN; UNSPECIFIC MONOOXYGENASE;

ARTICLE; CATALYSIS; DRUG OXIDATION; EMBRYO; EMBRYO DEVELOPMENT; FETUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIVER; MASS SPECTROMETRY; MODEL; PRIORITY JOURNAL;

CATALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; EMBRYONIC AND FETAL DEVELOPMENT; HUMANS; IMIPRAMINE; ISOENZYMES; LIVER; METHYLATION; OXIDATION-REDUCTION;

EID: 0032755003     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Brosen K, Skjelbo E and Nielsen KK (1996) Imipramine: A model drug for P450 research. Methods Enzymol 272 (Part B):177-186.
2. Carpenter SP, Lasker JM and Raucy JL (1996) Expression, induction and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver. Mol Pharmacol 49:260-268.
3. Carpenter SP, Savage DD, Schultz ED and Raucy JL (1997) Ethanol-mediated transplacental induction of CYP2E1 in fetal rat liver. J Pharmacol Exp Ther 282:1028-1036.
4. Chang TKH, Gonzalez FJ and Waxman DJ (1994) Evaluation of triacetyloleandomycin, α-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochrome P450. Arch Biochem Biophys 311:437-442.
5. Chapman DE, Yang HL, Watters J and Juchau MR(1994) Induction in vitro and complete coding region sequence of cytochrome P4501A1 cDNA from cultured whole rat conceptuses during early organogenesis. Biochem Pharmacol 48:1807-1814.
6. Chen H and Juchau MR (1997) Biotransformation of all-trans-retinal, 13-cis-retinal, and 9-cis-retinal catalyzed by conceptal cytosol and microsomes. Biochem Pharmacol 53:877-885.
7. 1. Cancer Res 54:101-108.
8. Juchau MR, Boutelet-Bochan H and Huang Y (1998) Cytochrome-P450-dependent biotransformation of xenobiotics in human and rodent embryonic tissues. Drug Metab Rev 30:541-568.
9. Kitada M, Taneda M, Itahashi K and Kamataki T (1991) Four forms of cytochrome P450 in human fetal liver: Purification and their capacity to activate promutagens. Jpn J Cancer Res 82:426-432.
10. Lemoine A, Gautier JC, Azoulay D, Kiffel L, Belloc C, Guengerich FP, Maurel P, Beaune P and Leroux JP (1993) Major pathway of imipramine metabolism is catalyzed by cytochrome P-450 1A2 and P-450 3A4 in human liver. Mol Pharmacol 43:827-832.
11. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
12. Madsen H, Rasmussen BB and Brosen K (1997) Imipramine demethylation in vivo: Impact of CYP1A2, CYP2C19, and CYP3A4. Clin Pharmacol Ther 61:319-324.
13. Miller MS, Juchau MR, Guengerich FP, Nebert DW and Raucy JL (1996) Drug metabolic enzymes in developmental toxicology. Fundam Appl Toxicol 34:165-176.
14. Ohmori S, Nakasa H, Asanome K, Kurose Y, Ishii I, Hosokawa M and Kitada M (1998) Differential catalytic properties in metabolism of endogenous and exogenous substrate among CYP3A enzymes expressed in COS-7 cells. Biochem Biophys Acta 1380:297-304.
15. Omiecinski CJ, Redlich CA and Costa P (1990) Induction and developmental expression of cytochrome P4501A1 messenger RNA in rat and human tissues: Detection by the polymerase chain reaction. Cancer Res 50:4315-4321.
16. Schuetz JD, Beach DL and Guzelian PS (1994) Selective expression of cytochrome P4503A mRNA in embryonic and adult human liver. Pharmacogenetics 4:11-20.
17. Sequeira DJ and Strobel HW (1995) High performance liquid chromatographic method for the analysis of imipramine metabolism in vitro by liver and brain microsomes. J Chromatogr B 673:251-258.
18. Shimada T, Yamazaki H, Mimura M, Wakamiya N, Ueng Y, Ouengerich FP and Inui Y (1996) Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs. Drug Metab Dispos 24:515-522.
19. Simon EB, Ahern D, Scatina J and Kao J (1997) Venlafaxine: In vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2. Br J Clin Pharmacol 43:619-626.
20. Wang RW and Lu AYH (1997) Inhibitory anti-peptide antibody against human CYP3A4. Drug Metab Dispos 25:762-767.